Marijuana: risks and short intervention

Česká verzia

Authors: K. Nešpor ¹; L. Csémy ²
Authors place of work: Oddělení léčby závislostí – muži, Psychiatrická léčebna Bohnice, Praha, Ředitel: MUDr. Martin Hollý ¹; Psychiatrické centrum Praha, Ředitel: prof. MUDr. Cyril Höschl, DrSc., FRCPsych ²
Published in the journal: Prakt. Lék. 2012; 92(8): 455-459
Category: Of different specialties

Summary

Cannabis abuse is a common problem in the Czech Republic and represents great risk for physical and mental health of the general population. Emphasizing therapeutic potential of cannabis may create false hope in patients and cause the neglect other forms of treatment. Beside this, the risks of this drug may be even more underestimated by lay persons. Medical doctors should take the widespread cannabis abuse into account and use brief interventions, wherever appropriate. Effectiveness of brief interventions for marihuana abuse was demonstrated even in the Czech Republic.

Key words:
Marijuana, epidemiology, risk, short intervention

Zdroje

1. Ashton, C.H. Pharmacology and effects of cannabis: a brief review. The British Journal of Psychiatry, 2001, 178, p. 101–106.

2. Bilbault, P., Duja, C.M., Bornemann, J.Y., et al.: Chest pain in young people: Is cannabis a risk factor? J Emerg Trauma Shock, 2010; 3(3): p. 307.

3. Bolla, K.I., Brown, K., Eldreth, D., et al.: Dose-related neurocognitive effects of marijuana use. Neurology, 2002, 59, p. 1337–1343.

4. Brook, J.S., Richter, L., Whiteman, M., Cohen, P.: Consequences of adolescent marijuana use: incompatibility with the assumption of adult roles. Genet Soc Gen Psychol Monogr, 1999, 125, p. 193-207.

5. Casadioa P, Fernandes C, Murray RM, Di Forti M. Cannabis use in young people: The risk for schizophrenia. Neurosci Biobehav Rev 2011; 35: p. 1779–1787.

6. Crean, R.D., Crane, N.A., Mason, B.J.: An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med, 2011; 5(1): p. 1-8.

7. Csémy, L., Kabíček, P., Hamanová, A., Kellerová, P.: Účinky krátkodobého a dlouhodobého užíváíní kanabionoidů. Čes-slov. Pediat, 2007; 62(3): s. 158–170.

8. Dinieri, J.A., Wang, X., Szutorisz, H., et al.: Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry, 2011 Aug 4. [Epub ahead of print].

9. Fernandes, S., Ferigolo, M., Benchaya, M.C., et al.: Brief motivational intervention and telemedicine: a new perspective of treatment to marijuana users. Addict Behav, 2010; 35(8): p. 750–755.

10. Sierro, I., Morales, C., Alvarez, F.J.: Alcohol use, illicit drug use, and road rage. J Stud Alcohol Drugs, 2011; 72(2): p. 185–193.

11. Ford, D.E., Vu, H.T., Anthony, J.C.: Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug Alcohol Depend, 2002, 67, p. 243-248.

12. Geberlich, S.G., Sidney, S., Braun, B.L., et al.: Marijuana use and injury events resulting in hospitalization. Ann Epidemiol, 2003; 13: p. 230–237.

13. Gérardin, M., Victorri-Vigneau, C., Louvigné, C., et al.: Management of cannabis use during pregnancy: an assessment of healthcare professionals’ practices. Pharmacoepidemiol Drug Saf, 2011; 20(5): p. 464–473.

14. Hall, W., Degenhardt, L.: Adverse health effects of non-medical cannabis use. Lancet, 2009; 374(9698): p. 1383–1391.

15. Hall, W., Linskey, M.: Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev, 2005; 24: p. 39–48.

16. Hartus, S., Csemy, L., Sherritt, L., et al.: Computerized SBIRT for adolescent substance use: comparison of outcomes in two countries, USA and Czech Republic. J Adolesc Health, 2011; 48(2): S14.

17. Hassan, A., Csémy, L, Rappo, M.A., A Knight, J.R.: Adolescent substance abuse around the world: an international perspective. Adolesc Med 2009; 20: p. 915–929.

19. Hibell, B., Guttormsson, U., Ahlström, S., et al.: The 2007 ESPAD report. Substance use among students in 35 European countries. The Swedish Council for Information on Alcohol and Other Drugs (CAN), Stockholm, 2009.

18. Honarmand, K., Tierney, M.C., O’Connor, P., Einstein, A.: Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurology, 2011; 76(13): p. 1153-1160.

20. Namlel, H.: American Glaucoma Society Position Statement: Marijuana and the treatment of glaucoma. J Glaucoma, 2010; 19(2): p. 75-76.

21. Krishnan, S., Cairns, R., Howard, R.: Cannabinoids for the treatment of dementia. Cochrane Database Syst Rev,. 2009;(2):CD007204.

22. Kuepper, R., van Os, J., Lieb, R., et al.: Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ, 2011; 342: d738.

23. Lombard, C., Hegde, V.L., Nagarkatti, M., Nagarkatti, P.S.: Perinatal exposure to {Delta}9-tetrahydrocannabinol (THC) triggers profound defects in T cell differentiation and function in fetal and post-natal stages of life including decreased responsiveness to HIV antigens. J Pharmacol Exp Ther, 2011 Aug 11. [Epub ahead of print].

24. Lorenzetti, V., Luxman, D.I., Whittle, S., et al.: Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse, 2010; 45(11): p. 1787-1808.

25. Lundqvist, T.: Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav, 2005; 81(2): p. 319–330.

26. Lynskey, M., Hall, W.: The effects of adolescent cannabis use on educational attainment: a review. Addiction, 95, 2000, p. 1621–1630.

27. Marijuana abuse. NIDA Research Report Series 2002; revised 2010 [on-line]. Dostupné na http://www.nida.nih.gov/ResearchReports/Marijuana/default.html.

28. Marmorstein, N.R., Iacono, W.G.: Explaining associations between cannabis use disorders in adolescence and later major depression: a test of the psychosocial failure model. Addict Behav, 2011; 36(7): p. 773–776.

29. Martin-Blondel, G., Koskas, F., Cacoub, P., Sène, D.: Is thromboangiitis obliterans presentation influenced by cannabis addiction? Ann Vasc Surg, 2011; 25(4): p. 469–473.

30. McCambridge, J., Slym, R.L., Strang, J.: Randomized controlled trial of motivational interviewing compared with drug information and advice for early intervention among young cannabis users. Addiction, 2008; 103(11): p. 1809–1818.

31. Mittleman, M.A., Lewis, R.A., Maclure, M., et al.: Triggering myocardial infarction by marijuana. Circulation, 2001; 103(23): p. 2805–2809.

32. Nešpor, K., Csémy, L., Zima, T.: Škodlivé účinky marihuany s odstupem několika let. Čas. Lék. čes. 2004; 143: s. 490–491.

33. Nešpor, K.: Krátká intervence a první pomoc pro lidi s návykovými nemocemi Prakt. Lék. 2011; 91(8): s. 483–486.

34. Nešpor, K.: Syndromy závislosti. In Raboch A. a spol. Psychiatrie:Doporučené postupy psychiatrické péče III. Česká psychiatrická společnost v nakladatelství Tribun EU, Brno 2010; s. 54-103. Dostupné na www.drnespor.eu.

35. NIDA: National Institute on Drug Abuse. NIDA InfoFacts: Marijuana, revised 2010 [on-line]. Dostupné na www.nida.nih.gov/PDF/InfoFacts/Marijuana.pdf.

36. Oeltmann, J.E., Oren, E., Haddad, M.B., et al.: Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis, 2006; 12(7): p. 1156–1159.

37. Pedersen W. Cannabis and social welfare assistance: a longitudinal study. Addiction, 2011; 106(9): p. 1636–1643.

38. Rey, J.M., Sawyer, M.G., Raphael, B., et al.: Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry, 2002, 180, p. 216–221.

39. Rockery, I.R., Putnam, S.L., Jia, H., Smith, G.S.: Declared and undeclared substance use among emergency department patients: a population-based study. Addiction, 2006; 101(5): p. 706–712.

40. Ronen, A., Chassidim, H.S., Gershon, P., et al.: The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. Accid Anal Prev, 2010; 42(6): p. 1855–1865.

41. Safra, A.M., Markham, R., Jayasinghe, R.: Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms. Drug Alcohol Rev, 2011. [Epub ahead of print].

42. Selvarajah, D., Sandhi, R., Emery, C.J., Tesfaye, S.: Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor. Diabetes Care, 2010; 33(1), p.128–30.

43. Singh, N.N., Pan, Y., Muengtaweeponsa, S., et al.: Cannabis-related stroke: case series and review of literature. J Stroke Cerebrovasc Dis, 2011 Mar 1. [Epub ahead of print].

44. Sousa S, Correia T, Ramos E, et al.: Violence in adolescents: social and behavioural factors. Gac Sanit, 2010; 24(1): p. 47–52.

45. Stanton, B., Cole, M., Galbraith, J., et al.: Randomized trial of a parent intervention: parents can make a difference in long-term adolescent risk behaviors, perceptions, and knowledge. Arch Pediatr Adolesc Med, 2004; 158(10): p. 947–955.

46. Stein, L.A., Lebedu, R., Colby, S.M., et al.: Motivational interviewing for incarcerated adolescents: effects of depressive symptoms on reducing alcohol and marijuana use after release. J Stud Alcohol Drugs, 2011; 72(3): p. 497–506.

47. Stein, M.D., Hagerty, C.E., Herman, D.S., et al.: A brief marijuana intervention for non-treatment-seeking young adult women. J Subst Abuse Treat, 2011; 40(2): p. 189–198.

48. Tashkin, D.P., Baldwin, G.C., Sarafian, T., et al.: Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol, 2002, 42, p. 71S–81S.

49. Taylor, D.R., Hall, W.: Respiratory health effects of cannabis: Position statement of the Thoracic Society of Australia and New Zealand. Intern Med J, 2003, 33(7), p. 310-313.

50. van Gastel WA, Wigman JT, Monshouwer K, et al.: Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction. 2011 Aug 18. [Epub ahead of print].

51. Wall MM, Poh E, Cerdá M, et al.: Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann Epidemiol, 2011; 21(9): p. 714-716.

52. Wallace EA, Andrews SE, Garmany CL, Jelley MJ. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. South Med J, 2011; 104(9): p. 659-664.

53. Woolard R, Nirenberg TD, Becker B, et al.: Marijuana use and prior injury among injured problem drinkers. Acad Emerg Med, 2003, 10: p. 43-51.